DEVELOPMENT OF A COMPOUND FOR THE TREATMENT OF COVID-19

Aligos Therapeutics, Inc., South San Francisco CA

Investigators

Abstract

To support the advanced development of a promising antiviral against a pathogen with pandemic potential. The research and development activities to be supported will allow the candidate therapeutic product to progress through the product development pathway, and include preclinical and IND enabling development activities, chemistry optimization/development, GMP manufacturing, and clinical safety and efficacy assessment.